Financhill
Sell
40

TERN Quote, Financials, Valuation and Earnings

Last price:
$3.00
Seasonality move :
-4.03%
Day range:
$2.94 - $3.14
52-week range:
$1.87 - $11.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.84x
Volume:
681.8K
Avg. volume:
1M
1-year change:
-49.6%
Market cap:
$275.1M
Revenue:
--
EPS (TTM):
-$1.09

Earnings Data

Next earnings date for TERN
Aug 05
2025
Most recent earnings per share
-$0.26
Beat by $0.01
(May 8/2025)
Consensus Estimate
-$0.27
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TERN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 -- -- -- -$0.29 --
05/08/2025 Q1 -- -- -$0.26 -$0.27 $0.01
03/20/2025 Q4 -- -- -$0.24 -$0.30 $0.06
11/12/2024 Q3 -- -- -$0.28 -$0.32 $0.04
08/05/2024 Q2 -- -- -$0.31 -$0.34 $0.03
05/13/2024 Q1 -- -- -$0.30 -$0.35 $0.05
03/14/2024 Q4 -- -- -$0.29 -$0.29 $0.00
11/14/2023 Q3 -- -- -$0.42 -$0.31 -$0.11
08/08/2023 Q2 -- -- -$0.25 -$0.33 $0.08
05/15/2023 Q1 -- -- -$0.31 -$0.27 -$0.04
03/27/2023 Q4 -- -- -$0.29 -- --
11/09/2022 Q3 -- -- -$0.44 -- --
08/08/2022 Q2 -- -- -$0.55 -- --
05/16/2022 Q1 -- -- -$0.55 -- --
03/03/2022 Q4 -- $1M -$0.56 -- --
11/15/2021 Q3 -- -- -$0.47 -- --
08/16/2021 Q2 -- -- -$0.43 -- --
05/14/2021 Q1 -- -- -$0.88 -- --
12/31/2020 Q4 -- -- $0.03 -- --
09/30/2020 Q3 -- -- -$0.48 -- --
06/30/2020 Q2 -- -- -$0.40 -- --
03/31/2020 Q1 -- -- -$0.38 -- --
12/31/2019 Q4 -- -- -$0.41 -- --

Terns Pharmaceuticals Earnings Questions

  • How Much did Terns Pharmaceuticals Generate in Revenue Last Quarter?

    Terns Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Terns Pharmaceuticals Beat Earnings Last Quarter?

    Terns Pharmaceuticals announced earnings per share of -$0.26 which represents a beat of analyst forecast a -$0.27 per share.

  • Is Terns Pharmaceuticals Profitable?

    Terns Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Terns Pharmaceuticals EPS Next Year?

    Terns Pharmaceuticals's earnings are forecast to decrease from -$1.12 per share to -$1.20 per share next year representing a decrease of -6.74%.

  • When is Terns Pharmaceuticals's Earnings Date?

    Terns Pharmaceuticals's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.

Buy
64
AKRO alert for May 22

Akero Therapeutics [AKRO] is up 1.56% over the past day.

Buy
86
AGYS alert for May 22

Agilysys [AGYS] is down 1.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock